老年癌症患者术后5年全因与癌症特异性死亡分析
结果显示5年癌症死亡累积发生率为20.7%,高于非癌症死亡的16.5%;但乳腺癌、前列腺癌、黑色素瘤皮肤癌患者及85岁以上或衰弱患者中,术后3年起非癌症死亡超过癌症死亡。
要点
- 老年癌症术后5年癌症死亡累积发生率20.7%,高于非癌症死亡的16.5%。
- 乳腺癌、前列腺癌、黑色素瘤皮肤癌及85岁以上或衰弱患者,术后3年起非癌症死亡超过癌症死亡。
- 癌症类型、高龄和衰弱与死因特异性死亡独立相关。
核心结论
- 在人群水平上,接受手术的老年癌症患者中癌症死亡负担高于非癌症死亡。
- 术后早期无亚组非癌症死亡负担更高,即使在高脆弱患者中也是如此。
研究设计与样本
- 采用竞争风险方法估计癌症与非癌症死亡的累积发生率,并拟合多因素亚分布风险模型探索预后因素。
主要发现
- 5年癌症死亡累积发生率为20.7%(95%CI 20.4%-21.0%),非癌症死亡为16.5%(95%CI 16.2%-16.8%)。
- 乳腺癌、前列腺癌、黑色素瘤皮肤癌患者,85岁以上患者及衰弱患者中,术后3年起非癌症死亡超过癌症死亡。
- 癌症类型、高龄和衰弱与死因特异性死亡独立相关。
临床怎么用
- 可利用死因特异性预后信息进行患者咨询。
- 可在系统层面评估老年癌症患者过度治疗或治疗不足的模式。
- 可指导系统改进目标,以优化老年癌症患者的选择标准和围术期护理路径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cancer care has inherent complexities in older adults, including balancing risks of cancer and noncancer death. A poor understanding of cause-specific outcomes may lead to overtreatment and undertreatment. OBJECTIVE: To examine all-cause and cancer-specific death throughout 5 years for older adults after cancer resection. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study was conducted in Ontario, Canada, using the administrative databases stored at ICES (formerly the Institute for Clinical Evaluative Sciences). All adults 70 years or older who underwent resection for a new diagnosis of cancer between January 1, 2007, and December 31, 2017, were included. Patients were followed up until death or censored at date of last contact of December 31, 2018. EXPOSURES: Cancer resection. MAIN OUTCOME AND MEASURES: Using a competing risks approach, the cumulative incidence of cancer and noncancer death was estimated and stratified by important prognostic factors. Multivariable subdistribution hazard models were fit to explore prognostic factors. RESULTS: Of 82 037 older adults who underwent surgery (all older than 70 years; 52 119 [63.5%] female), 16 900 of 34 044 deaths (49.6%) were cancer related at a median (interquartile range) follow-up of 46 (23-80) months. At 5 years, estimated cumulative incidence of cancer death (20.7%; 95% CI, 20.4%-21.0%) exceeded noncancer death (16.5%; 95% CI, 16.2%-16.8%) among all patients. However, noncancer deaths exceeded cancer deaths starting at 3 years after surgery in breast, prostate, and melanoma skin cancers, patients older than 85 years, and those with frailty. Cancer type, advancing age, and frailty were independently associated with cause-specific death. CONCLUSIONS AND RELEVANCE: At the population level, the relative burden of cancer deaths exceeds noncancer deaths for older adults selected for surgery. No subgroup had a higher burden of noncancer death early after surgery, even in more vulnerable patients. This cause-specific overall prognosis information should be used for patient counseling, to assess patterns of over- or undertreatment in older adults with cancer at the system level, and to guide targets for system-level improvements to refine selection criteria and perioperative care pathways for older adults with cancer.
引用
- Chesney TR, Coburn N, Mahar AL, et al. All-Cause and Cancer-Specific Death of Older Adults Following Surgery for Cancer. JAMA Surg. 2021. PMID: 33978695. doi:10.1001/jamasurg.2021.1425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。